Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients

Nephron - Clinical Practice

Volumn 118, Issue 4, 2011, Pages

  Fujimori, Akira ^a   Okada, Shioko ^a   Sakai, Makoto ^a   Tome, Katsuyuki ^a   Fukagawa, Masafumi ^b  

^a Konan Hospital   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biochemical marker; Bone loss; Hemodialysis; Parathyroid hormone; Radius

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; PARATHYROID HORMONE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; CORTICAL BONE; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RADIUS; RELATIVE CORTICAL AREA;

ACID PHOSPHATASE; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; BONE RESORPTION; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PARATHYROID HORMONE; RADIUS; RENAL DIALYSIS;

EID: 79851510882     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000323669     Document Type: Article

References (21)

1. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehmam-Breen C: Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000; 58: 396-399. (Pubitemid 30429887)
2. Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-1259. (Pubitemid 26147662)
3. Jamal SA, Gilbert J, Gordon C, Bauer DC: Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 2006; 21: 543-548.
4. Schober HC, Han ZH, Foldes AJ, Shin MS, RAO DS, Balena R, Parfitt AM: Mineralized bone loss at different sites in dialysis patients: Implication for prevention. J Am Soc Nephrol 1998; 9: 1225-1233. (Pubitemid 28283885)
5. Russo CR, Taccetti G, Caneva P, Mannarino A, Maranghi P, Ricca M: Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporosis Int 1998; 8: 443-448. (Pubitemid 28486712)
6. Fujimori A, Naito H, Miyazaki T, Azuma M, Tokukoda Y, Fujii Y: Measurement of cortical bone density in the radius by peripheral quantitative computed tomography in hemodialysis patients. Nephron 1997; 77: 240-241. (Pubitemid 27440419)
7. Leonard MB: A structural approach to skeletal fragility in chronic kidney disease. Semin Nephrol 2009; 29: 133-143.
8. Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD: Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: The OFELY study. J Bone Miner Res 1999; 14: 1614-1621. (Pubitemid 29416689)
9. Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I: The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res 2000; 15: 1537-1544. (Pubitemid 30484523)
10. Szulc P, Chapuy MC, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769-1774, comment 1268. (Pubitemid 23127383)
11. Garnero P, Delmas PD: Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993; 77: 1046-1053. (Pubitemid 23301484)
12. Igarashi Y, Mochizuki Y, Miura T, Ohashi T, Sasagawa K, Katayama K, Inaba N, Matsuzaki S: Evaluation of a novel immunoassay for serum tartrate-resistant acid phosphatase type5b activity in hormone replacement therapy. Bone 2003; 32:S179.
13. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Väänänen HK: Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption. J Bone Miner Res 2000; 15: 1337-1345. (Pubitemid 30413866)
14. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL: Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001; 16: 605-614. (Pubitemid 32230589)
15. Parfitt AM: A structural approach to renal bone disease. J Bone Miner Res 1998; 13: 1213-1220. (Pubitemid 28373321)
16. Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K: Effects of an excess and deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 2003; 88: 4655-4658. (Pubitemid 37357507)
17. Fujimori A, Yorifuji M, Sakai M, Oyama M, Nakao N, Tokuyama M, Fukagawa M: Lowcalcium dialysate improves mineral metabolism in hemodialysis patients. Clin Nephrol 2007; 67: 20-24. (Pubitemid 46321739)
18. Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T: IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker. Nephrol Dial Transplant 2003; 18(suppl 3):iii97-iii98. (Pubitemid 36826939)
19. Yamashita H, Gao P, Noguchi S, Cantor T, Uchino S, Watanabe S, Yamashita H, Kawamoto H, Fukagawa M: Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: Potential improvement of intraoperative PTH assay. Ann Surg 2002; 236: 105-111. (Pubitemid 34686457)
20. Uena P, Bernard-Poenaru O, Ostertag: A bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 2325-2331. (Pubitemid 37345093)
21. Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR: Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 1996; 125: 360-368, comment 413-415. (Pubitemid 126449705)